Marta Domenech - Publications

Regulatory delay and lost opportunity in IDH-mutant low-grade glioma.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: May 26, 2026

ARIAN protocol: a phase III study of sacituzumab and zimberelimab for the treatment of patients with non-small cell lung cancer.

Journal: Expert opinion on biological therapy

Published: May 20, 2026

Implementing a molecular prescreening strategy for tumors without public NGS access in a cancer center network: Results from the PREICO project.

Journal: European journal of cancer (Oxford, England : 1990)

Published: January 11, 2026

Clinical actionability in gliomas revealed by real-world next-generation sequencing: a multicentric study.

Journal: NPJ precision oncology

Published: June 16, 2025

Multikinase Treatment of Glioblastoma: Evaluating the Rationale for Regorafenib.

Journal: Cancers

Published: December 05, 2024

The C250T Mutation of TERTp Might Grant a Better Prognosis to Glioblastoma by Exerting Less Biological Effect on Telomeres and Chromosomes Than the C228T Mutation.

Journal: Cancers

Published: January 16, 2024

The S-REAL study: Spanish real-world data on unresectable stage III NSCLC patients treated with durvalumab after chemoradiotherapy.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: November 08, 2023